Dernières nouvelles
Information non disponible
Rosiglitazone lowers resting and blood pressure response to exercise in men with type 2 diabetes: A 1-year randomized study
Article de revueDiabetes Obes Metab, 20 (7), 2018.
Signaler des ajouts ou des modifications